跳至主要内容
临床试验/DRKS00025711
DRKS00025711招募中不适用

Myasthenia gravis - In-depth characterization of antibody-specific pathomechanisms and identification of novel autoantibodies. - MYA-IN-DEPTH

Klinik für Neurologie, Charité- Universitätsmedizin Berlin0 个研究点目标入组 150 人开始时间: 2021年9月7日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patient capable of written informed consent
  • - Adult patients
  • MG patients:
  • - Seronegative MG patients for whom an intercostal muscle biopsy is planned within standard care (i.e. in case of diagnostic uncertainty or in case of therapy refractory disease course to assess the possibility of a targeted complement inhibition)
  • - AchR-Ak-positive MG patients for whom thymectomy is planned as part of standard care (positive controls”).
  • Participants of the control group (negative controls”):
  • - Patients for whom a thoracoscopy/thoracotomy is planned for a non-myasthenic indication (e.g. traumatic injuries)

排除标准

  • Participants in the control group (negative controls):
  • - Known rheumatic or tumor diseases

研究者

发起方
Klinik für Neurologie, Charité- Universitätsmedizin Berlin

相似试验